Cancer Lett. 2023 Mar 10. pii: S0304-3835(23)00075-7. [Epub ahead of print] 216124
Triple-negative breast cancer (TNBC), although highly lethal, lacks validated therapeutic targets. Here, we report that U2 snRNP-associated SURP motif-containing protein (U2SURP), a poorly defined member of the serine/arginine rich protein family, was significantly upregulated in TNBC tumors, and its high expression was associated with poor prognosis. MYC, a frequently amplified oncogene in TNBC tumors, enhanced U2SURP translation through an eIF3D (eukaryotic translation initiation factor 3 subunit D)-dependent mechanism, resulting in accumulation of U2SURP in TNBC tissues. Functional assays revealed that U2SURP played an important role in facilitating tumorigenesis and metastasis of TNBC both in vitro and in vivo. Intriguingly, U2SURP had no significant effects on proliferation, migratory and invasive potential of normal mammary epithelial cells. Furthermore, we found that U2SURP promoted alternative splicing of spermidine/spermine N1-acetyltransferase 1 (SAT1) pre-mRNA by removal of intron 3, increasing the stability of SAT1 mRNA and subsequent protein expression levels. Importantly, spliced SAT1 promoted the oncogenic properties of TNBC cells, and re-expression of SAT1 in U2SURP-silencing cells partially rescued the impaired malignant phenotypes of TNBC cells caused by U2SURP knockdown both in vitro and in mice. The MYC-U2SURP-SAT1 signaling axis is a potential target in the treatment of TNBC.
Keywords: Cap-dependent translation; SR protein; Splicing switch; Therapeutic target; Transcription regulation